$738.06
2.72% yesterday
NYSE, Oct 03, 10:00 pm CET
ISIN
US58155Q1031
Symbol
MCK

McKesson Stock price

$738.06
+47.22 6.84% 1M
+21.13 2.95% 6M
+168.15 29.50% YTD
+255.79 53.04% 1Y
+391.32 112.86% 3Y
+588.88 394.74% 5Y
+548.35 289.05% 10Y
+690.34 1,446.65% 20Y
NYSE, Closing price Fri, Oct 03 2025
-20.64 2.72%

Key metrics

Basic
Market capitalization
$91.8b
Enterprise Value
$97.2b
Net debt
$5.4b
Cash
$2.4b
Shares outstanding
125.0m
Valuation (TTM | estimate)
P/E
29.3 | 19.4
P/S
0.2 | 0.2
EV/Sales
0.3 | 0.2
EV/FCF
17.1
P/B
negative
Dividends
DPS
$2.75
Yield 1Y | 5Y
0.4% | 0.6%
Growth 1Y | 5Y
14.6% | 11.2%
Payout 1Y | 3Y
10.7% | 9.9%
Increased
12 Years
Financials (TTM | estimate)
Revenue
$377.6b | $411.9b
EBITDA
$5.7b | $6.7b
EBIT
$5.0b | $6.2b
Net Income
$3.2b | $4.7b
Free Cash Flow
$5.7b
Growth (TTM | estimate)
Revenue
20.4% | 14.7%
EBITDA
23.3% | 32.3%
EBIT
27.6% | 40.4%
Net Income
6.9% | 44.1%
Free Cash Flow
74.0%
Margin (TTM | estimate)
Gross
3.5%
EBITDA
1.5% | 1.6%
EBIT
1.3%
Net
0.8% | 1.2%
Free Cash Flow
1.5%
Financial Health
Equity Ratio
-2.8%
Return on Equity
-158.9%
ROCE
29.7%
ROIC
-
Debt/Equity
-4.0
More
EPS
$25.2
FCF per Share
$45.3
Short interest
1.5%
Employees
48k
Rev per Employee
$7.5m
Show more

Is McKesson a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

McKesson Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a McKesson forecast:

18x Buy
82%
4x Hold
18%

Analyst Opinions

22 Analysts have issued a McKesson forecast:

Buy
82%
Hold
18%

Financial data from McKesson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
377,595 377,595
20% 20%
100%
- Direct Costs 364,512 364,512
21% 21%
97%
13,083 13,083
3% 3%
3%
- Selling and Administrative Expenses 8,036 8,036
9% 9%
2%
- Research and Development Expense - -
-
-
5,671 5,671
23% 23%
2%
- Depreciation and Amortization 624 624
3% 3%
0%
EBIT (Operating Income) EBIT 5,047 5,047
28% 28%
1%
Net Profit 3,164 3,164
7% 7%
1%

In millions USD.

Don't miss a Thing! We will send you all news about McKesson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

McKesson Stock News

Positive
FXEmpire
3 days ago
McKesson Corporation (MCK) shares up 138.5% since Big Money bought big in May 2022.
Neutral
Seeking Alpha
11 days ago
McKesson Corporation (NYSE:MCK ) Analyst/Investor Day September 23, 2025 9:30 AM EDT Company Participants Brian Tyler - CEO & Director Britt Vitalone - Executive VP & CFO Kirk Kaminsky - President of The US Pharmaceutical & Specialty Solutions Business Joan Eliasek - President Jason Hammonds Kevin Kettler Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division George Hil...
Positive
Reuters
11 days ago
McKesson on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.
More McKesson News

Company Profile

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Head office United States
CEO Brian Tyler
Employees 48,000
Founded 1833
Website www.mckesson.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today